The identified cell-signaling molecules and pathways that are involved in regulating CAP1, as well as mediating CAP1 signals, including GSK3, FAK, and ERK, may be therapeutic targets in novel treatment strategies for breast cancer and potentially other cancer types, especially from the perspective of targeting CAP1-related cell signals. The gene discussed is CAP1; the disease is breast carcinoma.